Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
Mar 31, 2020
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%
Mar 30, 2020
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Mar 30, 2020
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Mar 25, 2020
2020 Insights into Calcitonin Gene Related Peptide Type 1 Receptor - Featuring Adepthera, Allergan and Amgen Among Others
Mar 23, 2020
Global Hidradenitis Suppurativa (HS) Industry Assessment, 2020 Featuring InflaRx, Novartis Pharma, Incyte Corp, UCB Biopharma, and Janssen Pharma
Mar 20, 2020
Oncopeptides Provides Update Regarding COVID-19 Impact on the Melflufen Clinical Program
Mar 18, 2020
GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma
Mar 18, 2020
Visiongain Report: Global Rheumatoid Arthritis Drugs Market Estimated to Grow at a CAGR of 0.6% in the Second Half of the Forecast Period
Mar 17, 2020
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program
Mar 16, 2020
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19
Mar 16, 2020
2020 Market Spotlight: Small-Cell Lung Cancer (SCLC)
Mar 12, 2020
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Mar 12, 2020
Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Mar 10, 2020
2020 Disease Analysis: Multiple Sclerosis - Sanofi to Co-Develop Digital Therapeutic for MS Patients
Mar 02, 2020
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Mar 02, 2020
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
‹‹
Page 5
››
Latest News
Apr 25, 2024
Mercedes-Benz AG Hosts Event to Test CCC Digital Key Specification with UWB and Bluetooth LE
Apr 25, 2024
Littelfuse to Present at Upcoming Investor Conferences
Apr 25, 2024
Elastomers Applications and Global Market Analysis 2024: Key Opportunities for Sustainable Elastomer Products...
Apr 25, 2024
DISA Validates Security Technical Implementation Guide (STIG) for Mirantis Kubernetes Engine
Apr 25, 2024
Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System
Apr 25, 2024
Global Supercapacitors/Ultracapacitors Industry Research 2023-2033: Opportunities in Expanding Applications...
Apr 25, 2024
Transition Industries LLC and JAPAMA announce public-private partnership to develop innovative and...
Apr 25, 2024
Sunday Swagger Expands Product Line with Bold New Designs and Limited Editions for Spring
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events